{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:22:55Z","timestamp":1790504575587,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,23]],"date-time":"2014-11-23T00:00:00Z","timestamp":1416700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,11,23]],"date-time":"2014-11-23T00:00:00Z","timestamp":1416700800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s12013-014-0314-9","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T08:24:47Z","timestamp":1417508687000},"page":"1097-1104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["High-Dose Methotrexate (HD-MTX) Used as an Adjunct with Other Chemotherapeutics for the Treatment of Osteosarcoma"],"prefix":"10.1007","volume":"71","author":[{"given":"Yunxia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yefeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoming","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,23]]},"reference":[{"issue":"10","key":"314_CR1","first-page":"870","volume":"28","author":"Y Hu","year":"2008","unstructured":"Hu, Y., Wan, Y., et al. (2008). Minutes of The second national conference on neoadjuvant chemotherapy of Osteosarcoma Expert Meeting. Chin J Orthop,\n                  28(10), 870\u2013874.","journal-title":"Chin J Orthop"},{"issue":"supplement","key":"314_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00625054","volume":"106","author":"G Rosen","year":"1983","unstructured":"Rosen, G., Marcove, R. C., & Huvos, A. G. (1983). Primary osteogenic sarcoma: Eight-year experience with adjuvant chemotherapy. Journal of Cancer Research and Clinical Oncology,\n                  106(supplement), 55\u201367.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"23","key":"314_CR3","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1002\/cncr.27651","volume":"118","author":"NM Bernthal","year":"2012","unstructured":"Bernthal, N. M., Federman, N., Eilber, F. R., et al. (2012). Long-term results (>25\u00a0years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with high-grade, operable osteosarcoma. Cancer,\n                  118(23), 5888\u20135893.","journal-title":"Cancer"},{"issue":"7","key":"314_CR4","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.1998.16.7.2452","volume":"16","author":"PA Meyers","year":"1998","unstructured":"Meyers, P. A., Gorlick, R., Heller, G., et al. (1998). Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. Journal of Clinical Oncology,\n                  16(7), 2452\u20132458.","journal-title":"Journal of Clinical Oncology"},{"issue":"25","key":"314_CR5","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1056\/NEJM198606193142502","volume":"314","author":"MP Link","year":"1986","unstructured":"Link, M. P., Goorin, A. M., & Miser, A. W. (1986). The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. New England Journal of Medicine,\n                  314(25), 1600\u20131606.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"314_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1200\/JCO.1987.5.1.21","volume":"5","author":"F Eilber","year":"1987","unstructured":"Eilber, F., Giuliano, A., & Eckhardt, J. (1987). Adjuvant chemotherapy for osteosarcoma: A randomized prospective trial. Journal of Clinical Oncology,\n                  5(1), 21\u201326.","journal-title":"Journal of Clinical Oncology"},{"key":"314_CR7","unstructured":"Jaffe, N. (2014). Historical perspective on the introduction and use of chemotherapy for the treatment of osteosarcoma in current advances in osteosarcoma. In: Kleinerman, E. S. (Ed.), Advances in experimental medicine and biology (Vol 804, pp. 1\u201330). University Springer Cham Heidelberg New York Dordrecht London Springer International Publishing Switzerland."},{"key":"314_CR8","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ejca.2006.10.023","volume":"43","author":"M-C Le Deley","year":"2007","unstructured":"Le Deley, M.-C., Guinebretiere, J.-M., Gentet, J.-C., Pacquement, H., et al. (2007). SFOP OS94: A randomised trial comparing preoperative high-dose methotrexate plus doxorubicin to high-dose methotrexate plus etoposide and ifosfamide in osteosarcoma patients. European Journal of Cancer,\n                  43, 752\u2013761.","journal-title":"European Journal of Cancer"},{"key":"#cr-split#-314_CR9.1","doi-asserted-by":"crossref","unstructured":"Haddox, C. L., Han, G., Anijar, L., Binitie, O., Letson, G. D., Bui, M. M., Damon, R., & Reed, D. R. (2014). Osteosarcoma in pediatric patients and young adults: A single institution retrospective review of presentation, therapy,","DOI":"10.1155\/2014\/402509"},{"key":"#cr-split#-314_CR9.2","unstructured":"and outcome. Sarcoma, Volume 2014, Article ID 402509."},{"key":"314_CR10","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s12032-014-0936-1","volume":"31","author":"I Kushnir","year":"2014","unstructured":"Kushnir, I., Kolander, Y., Bickels, J., Gortzak, Y., Flusser, G., Issakov, J., et al. (2014). Is it important to maintain high-dose intensity chemotherapy in the treatment of adults with osteosarcoma? Medical Oncology,\n                  31, 936.","journal-title":"Medical Oncology"},{"issue":"6","key":"314_CR11","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1002\/1097-0142(197906)43:6<2163::AID-CNCR2820430602>3.0.CO;2-S","volume":"43","author":"G Rosen","year":"1979","unstructured":"Rosen, G., Marcove, R. C., Caparros, B., Nirenberg, A., Kosloff, C., & Huvos, A. G. (1979). Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer,\n                  43(6), 2163\u20132177.","journal-title":"Cancer"},{"issue":"6","key":"314_CR12","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/1097-0142(19820315)49:6<1221::AID-CNCR2820490625>3.0.CO;2-E","volume":"49","author":"G Rosen","year":"1982","unstructured":"Rosen, G., Caparros, B., Huvos, A. G., et al. (1982). Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer,\n                  49(6), 1221\u20131230.","journal-title":"Cancer"},{"key":"314_CR13","unstructured":"Bacci, G., Ferrari, S., Lari, S., et al. (2002). Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. Journal of Bone & Joint Surgery, 84(1):88\u201392."},{"key":"314_CR14","unstructured":"Eselgrim, M., Grunert, H., K\u00fchne, T., et al. (2006). Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials. Pediatric Blood & Cancer, 47(1):42\u201350."},{"issue":"24","key":"314_CR15","first-page":"4028","volume":"18","author":"IJ Lewis","year":"2000","unstructured":"Lewis, I. J., Weeden, S., Machin, D., Stark, D., & Craft, A. W. (2000). Received dose and dose-intensity of chemotherapy and outcome in nonmetastatic extremity osteosarcoma. European Osteosarcoma Intergroup. J Clin Oncol.,\n                  18(24), 4028\u20134037.","journal-title":"European Osteosarcoma Intergroup. J Clin Oncol."},{"issue":"8","key":"314_CR16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1023\/A:1008391103132","volume":"9","author":"N Fuchs","year":"1998","unstructured":"Fuchs, N., Bielack, S. S., Epler, D., et al. (1998). Long-term results of the cooperative German-Austrian-Swiss osteosarcoma study group\u2019s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Annals of Oncology,\n                  9(8), 893\u2013899.","journal-title":"Annals of Oncology"},{"key":"314_CR17","doi-asserted-by":"crossref","unstructured":"Gentet, J.-C., Brunat-Mentigny, M., Demaille, M. C., Pein, F, Avet-Loiseau, H., et al. Ifosfamide and etoposide in childhood osteosarcoma. A phase II study of the French Society of Paediatric Oncology. European Journal of Cancer, 33(2):232\u2013237.","DOI":"10.1016\/S0959-8049(96)00439-X"},{"key":"314_CR18","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1002\/cncr.21724","volume":"106","author":"G Bacci","year":"2006","unstructured":"Bacci, G., Longhi, A., Versari, M., Mercuri, M., Briccoli, A., & Picci, P. (2006). Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy 15-year experience in 789 patients treated at a single Institution. Cancer,\n                  106, 1154\u20131161.","journal-title":"Cancer"},{"issue":"8","key":"314_CR19","doi-asserted-by":"publisher","first-page":"e71362","DOI":"10.1371\/journal.pone.0071362","volume":"8","author":"S Miwa","year":"2013","unstructured":"Miwa, S., Takeuchi, A., Ikeda, H., Shirai, T., Yamamoto, N., et al. (2013). Prognostic value of histological response to chemotherapy in osteosarcoma patients receiving tumor-bearing frozen autograft. PLoS ONE,\n                  8(8), e71362.","journal-title":"PLoS ONE"},{"issue":"2","key":"314_CR20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1200\/JCO.1994.12.2.423","volume":"12","author":"AM Davis","year":"1994","unstructured":"Davis, A. M., Bell, R. S., & Goodwin, P. J. (1994). Prognostic factors in osteoarcoma:a critical review. Journal of Clinical Oncology,\n                  12(2), 423\u2013431.","journal-title":"Journal of Clinical Oncology"},{"key":"314_CR21","doi-asserted-by":"publisher","unstructured":"Liu, S., Yi, Z., Ling, M., Shi, J., Qiu, Y., & Yang, S. Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy. Tumor Biology. doi:\n                    10.1007\/s13277-014-1917-x\n                    \n                  .","DOI":"10.1007\/s13277-014-1917-x"},{"issue":"7","key":"314_CR22","first-page":"666","volume":"30","author":"Xin Sun","year":"2010","unstructured":"Sun, Xin, Guo, Wei, & Yang, Rongli. (2010). Follow-up analysis of 99 cases of non-metastatic Osteosarcoma. Chinese Journal of Orthopaedics,\n                  30(7), 666\u2013671.","journal-title":"Chinese Journal of Orthopaedics"},{"key":"314_CR23","doi-asserted-by":"crossref","unstructured":"Meyers, P. A., Heller, G., & Healey, J. H. et al. (1993). Osteogenic sarcoma with clinically detectable metastasis at initial presentation. Journal of Clinical Oncology, 11, 449\u2013453.","DOI":"10.1200\/JCO.1993.11.3.449"},{"key":"314_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/(SICI)1097-0142(19970115)79:2<245::AID-CNCR7>3.0.CO;2-J","volume":"79","author":"G Bacci","year":"1997","unstructured":"Bacci, G., Mercuri, M., Bnccoli, A., et al. (1997). Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions. Cancer,\n                  79, 245\u2013254.","journal-title":"Cancer"},{"key":"314_CR25","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1200\/JCO.1998.16.11.3641","volume":"16","author":"MB Harris","year":"1998","unstructured":"Harris, M. B., Gieser, P., Goorin, A. M., et al. (1998). Treatment of metastatic osteosarcoma at diagnosis: A Pediatric Oncology Group Study. Journal of Clinical Oncology,\n                  16, 3641\u20133648.","journal-title":"Journal of Clinical Oncology"},{"issue":"22","key":"314_CR26","first-page":"1730","volume":"46","author":"X Niu","year":"2008","unstructured":"Niu, X., & Ding, Y. (2008). Treatment for Osteosarcoma with pathological fractures. Chin J Surg,\n                  46(22), 1730\u20131733.","journal-title":"Chin J Surg"},{"issue":"8","key":"314_CR27","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1023\/A:1011636912674","volume":"12","author":"S Ferrari","year":"2001","unstructured":"Ferrari, S., Bertoni, F., Mercuri, M., et al. (2001). Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: An analysis of 300 patients treated at the Rizzoli Institute. Annals of Oncology,\n                  12(8), 1145\u20131150.","journal-title":"Annals of Oncology"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0314-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12013-014-0314-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0314-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-0314-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T14:32:34Z","timestamp":1602253954000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12013-014-0314-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,23]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["314"],"URL":"https:\/\/doi.org\/10.1007\/s12013-014-0314-9","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,23]]},"assertion":[{"value":"23 November 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}